🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, multi-center, double blind, placebo controlled study to ...
Status
Terminated
Location
St. Paul's Hospital - Pacific Lung Health Centre (PLHC)
Start Date
2017-01-03
Trial ID
NCT02955888
This is a Phase 2, open-label, single-arm study of the safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02562573
Treatments Being Tested
The purpose of this study is to investigate the study drug PBI-4050 to dete...
Status
Completed
Location
Covance CRU, Ltd.
Start Date
2020-12-09
Trial ID
NCT04695041
Treatments Being Tested
This is a Phase 2, single-centre, single-arm, open-label study of the safet...
Status
Completed
Location
University Hospitals Birmingham NHS Foundation Trust
Start Date
2016-02-22
Trial ID
NCT02739217
Treatments Being Tested
This is a Phase 2, open-label, single-arm study of the safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02538536
Treatments Being Tested
The purpose of this study is to compare the safety, tolerability and pharma...
Status
Terminated
Location
Celerion
Start Date
2022-05-13
Trial ID
NCT05349435
Treatments Being Tested
This is a Phase 2, multi-center, double-blind, placebo-controlled study of ...
Status
Terminated
Location
C-Health
Start Date
2017-05-29
Trial ID
NCT03081598
This study is designed to evaluate the pharmacokinetics (PK) and safety of ...
Status
Completed
Location
Celerion
Start Date
2018-07-17
Trial ID
NCT03637049
Treatments Being Tested
Phase 2, open-label, single-arm, multi-centre study evaluating the long ter...
Status
Terminated
Location
University Hospitals Birmingham NHS Foundation Trus
Start Date
2017-10-09
Trial ID
NCT03184584
Treatments Being Tested